Literature DB >> 18432996

Generation of Epstein-Barr Virus (EBV)-immortalized B cell lines.

Giovanna Tosato1, Jeffrey I Cohen.   

Abstract

Immortalization of B lymphocytes by EBV is an effective procedure for inducing long-term growth of certain human B lymphocytes. The protocol described in this unit to accomplish this can be divided into three stages: preparation of virus, preparation of target cells to be immortalized, and EBV infection and growth of infected cells.

Entities:  

Mesh：

Year:  2007        PMID： 18432996     DOI： 10.1002/0471142735.im0722s76

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN： 1934-3671


  36 in total

1.  Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.

Authors:  Yuka Okura; Masafumi Yamada; Futoshi Kuribayashi; Ichiro Kobayashi; Tadashi Ariga
Journal:  J Clin Immunol       Date:  2015-02-10       Impact factor: 8.317

2.  Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells.

Authors:  Henri-Alexandre Michaud; Devi SenGupta; Miguel de Mulder; Steven G Deeks; Jeffrey N Martin; James J Kobie; Jonah B Sacha; Douglas F Nixon
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

3.  Mislocalization or low expression of mutated Shwachman-Bodian-Diamond syndrome protein.

Authors:  Masafumi Yamaguchi; Kingo Fujimura; Hirokazu Kanegane; Hanae Toga-Yamaguchi; Rajesh Chopra; Naoki Okamura
Journal:  Int J Hematol       Date:  2011-06-10       Impact factor: 2.490

Review 4.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

5.  A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines.

Authors:  Xi Liu; Chongfeng Xu; Ziyuan Duan
Journal:  J Vis Exp       Date:  2017-01-14       Impact factor: 1.355

6.  C2orf69 mutations disrupt mitochondrial function and cause a multisystem human disorder with recurring autoinflammation.

Authors:  Eva Lausberg; Sebastian Gießelmann; Joseph P Dewulf; Elsa Wiame; Anja Holz; Ramona Salvarinova; Clara D van Karnebeek; Patricia Klemm; Kim Ohl; Michael Mull; Till Braunschweig; Joachim Weis; Clemens J Sommer; Stephanie Demuth; Claudia Haase; Claudia Stollbrink-Peschgens; François-Guillaume Debray; Cecile Libioulle; Daniela Choukair; Prasad T Oommen; Arndt Borkhardt; Harald Surowy; Dagmar Wieczorek; Norbert Wagner; Robert Meyer; Thomas Eggermann; Matthias Begemann; Emile Van Schaftingen; Martin Häusler; Klaus Tenbrock; Lambert van den Heuvel; Miriam Elbracht; Ingo Kurth; Florian Kraft
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

7.  Three steps to breaking immune tolerance to lymphoma: a microparticle approach.

Authors:  Amani Makkouk; Vijaya B Joshi; Caitlin D Lemke; Amaraporn Wongrakpanich; Alicia K Olivier; Sue E Blackwell; Aliasger K Salem; George J Weiner
Journal:  Cancer Immunol Res       Date:  2015-01-27       Impact factor: 11.151

8.  A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.

Authors:  Rebecca A Marsh; Joyce Villanueva; Kejian Zhang; Andrew L Snow; Helen C Su; Lisa Madden; Rajen Mody; Brenda Kitchen; Dan Marmer; Michael B Jordan; Kimberly A Risma; Alexandra H Filipovich; Jack J Bleesing
Journal:  Cytometry B Clin Cytom       Date:  2009-09       Impact factor: 3.058

9.  Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness.

Authors:  Chantal Lagresle-Peyrou; Emmanuelle M Six; Capucine Picard; Frédéric Rieux-Laucat; Vincent Michel; Andrea Ditadi; Corinne Demerens-de Chappedelaine; Estelle Morillon; Françoise Valensi; Karen L Simon-Stoos; James C Mullikin; Lenora M Noroski; Céline Besse; Nicolas M Wulffraat; Alina Ferster; Manuel M Abecasis; Fabien Calvo; Christine Petit; Fabio Candotti; Laurent Abel; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Nat Genet       Date:  2008-11-30       Impact factor: 38.330

10.  C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells.

Authors:  Rustam Esanov; Kinsley C Belle; Marka van Blitterswijk; Veronique V Belzil; Rosa Rademakers; Dennis W Dickson; Leonard Petrucelli; Kevin B Boylan; Derek M Dykxhoorn; Joanne Wuu; Michael Benatar; Claes Wahlestedt; Zane Zeier
Journal:  Exp Neurol       Date:  2015-12-31       Impact factor: 5.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.